NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Current Deferred Revenue (2021 - 2022)

Updated

NRX Pharmaceuticals' Current Deferred Revenue was $56,000 in Q3 2022, down 95.6% from $1.26 million a year earlier but up 194.7% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Current Deferred Revenue (2021 - 2022) Analysis & Trends

At the end of FY2021, Current Deferred Revenue at NRX Pharmaceuticals came in at $292,000.

  • Quarterly Current Deferred Revenue has moved between $19,000 (Q2 2022) and $22.85 million (Q2 2021) over five years.
  • Per Business Quant data, NRXP's Current Deferred Revenue in the three quarters before Q3 2022 was $19,000 (Q2 2022), $135,000 (Q1 2022) and $292,000 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 56,000.00
Jun 30, 2022 19,000.00
Mar 31, 2022 135,000.00
Dec 31, 2021 292,000.00
Sep 30, 2021 1.26 Mn
Jun 30, 2021 22.85 Mn
API Access

NRX Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NRXP&period=max&api_key=YOUR_API_KEY